Broker Ratings

Waters Corporation – Consensus ‘hold’ rating and -4.5% Downside Potential

Waters Corporation which can be found using ticker (WAT) have now 16 market analysts covering the stock. The analyst consensus now points to a rating of ‘hold’. The range between the high target price and low target price is between $380.00 and $300.00 suggesting an average Analsyt target price of $341.30. Given that the stocks previous close was at $357.33 this indicates there is a potential downside of -4.5%. The day 50 moving average is $333.78 and the 200 day MA is $324.53. The market capitalization for the company is 21.36B. The current share price for the company is: $359.89 USD

The potential market cap would be $20,405,366,424 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 35.99, revenue per share of $48.45 and a 11.17% return on assets.

Waters Corporation is a specialty measurement company. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. Its segments include Waters and TA. The Waters segment is primarily in the business of designing, manufacturing, selling and servicing liquid chromatography (LC) and MS instrument systems, columns and other precision chemistry consumables that can be integrated and used along with other analytical instruments. The TA segment is primarily in the business of designing, manufacturing, selling and servicing thermal analysis, rheometry and calorimetry instruments. The Company’s products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic and government customers.

Share on:
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Waters Corporation (WAT) Stock Analysis: A Promising 5.92% Potential Upside for Healthcare Investors

    Waters Corporation (NYSE: WAT), a significant player in the healthcare sector, particularly within the diagnostics and research industry, presents an intriguing opportunity for investors. With a market capitalization of $19.92

    Waters Corporation (WAT) Investor Outlook: Exploring a 6% Upside with Robust Revenue Growth

    Waters Corporation (WAT), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, has been capturing the attention of investors with its innovative solutions and consistent

    Waters Corporation (WAT) Stock Analysis: Navigating a 5.41% Potential Upside in the Healthcare Sector

    Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, particularly in the diagnostics and research industry, stands as a significant entity for investors seeking exposure to analytical workflow

    Waters Corporation (WAT) Stock Analysis: Navigating a 19% Potential Upside with Strategic Insights

    Waters Corporation (NYSE: WAT), a stalwart in the healthcare sector’s diagnostics and research industry, continues to be a focal point for investors seeking opportunities within analytical workflow solutions. With a

    Waters Corporation (WAT)

    ⚠️ No article content returned. You might also enjoy reading  Waters Corporation (WAT) Stock Analysis: Exploring a 16% Upside Potential in the Diagnostics & Research Sector

    Waters Corporation (WAT) Stock Analysis: A Healthcare Giant with 15.38% Upside Potential

    Waters Corporation (NYSE: WAT), a prominent player in the Healthcare sector, particularly within the Diagnostics & Research industry, presents an intriguing opportunity for investors seeking exposure to cutting-edge analytical technology

      Search

      Search